Organization
National Cancer Center Research Institute
7 abstracts
Abstract
Insights from C-CAT repository: A novel approach to identifying appropriate patient populations for anticancer drug development using the clinicogenomic nationwide database in Japan.Org: National Cancer Center Research Institute, National Cancer Center Hospital East, Kashiwa, Japan, Division of Genome Biology, Department of Medical Oncology, State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Department of Experimental Therapeutics, National Cancer Center Hospital East,
Abstract
Tumor microenvironment-mediated immune profiles and efficacy of platinum doublet chemotherapy plus ICIs stratified by DLL3 expression in small cell lung cancer.Org: National Cancer Center Hospital East, Kashiwa, Japan, Division of Genome Biology, National Cancer Center Research Institute, Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, Department of Respiratory Medicine, NHO Iwakuni Clinical Center, Iwakuni, Japan,
Abstract
Ombipepimut dosing emulsion (ODE) + bevacizumab (bev) vs bev alone in patients (pts) with recurrent or progressive glioblastoma (rGBM).Org: John Theurer Cancer Center at Hackensack Meridian Health, HMH School of Medicine, Hackensack, NJ, Hackensack University Medical Center, Severance Hospital, Department of Neurosurgery and Neuro-Oncology, National Cancer Center Research Institute, Tokyo, Japan, National Cancer Center Research Institute,
Abstract
Development and validation of a prediction model for the recurrence of stage 1 EGFR mutation positive NSCLC in patients using machine learning with WES-based gene sets.Org: National Cancer Center Hospital East, Kashiwa, Japan, National Cancer Center Research Institute,
Abstract
Feasibility and utility of the custom RNA-seq for the identification of therapeutic targets and diagnostic biomarkers in glioma.Org: Department of Neurosurgery and Neuro-Oncology, National Cancer Center Research Institute, Tokyo, Japan, National Cancer Center Hospital East, Kashiwa, Japan, Division of Cellular Signaling, National Cancer Center Research Institute, Department of Brain Disease Translational Research,
Abstract
Trends in the needs and clinical utility of comprehensive genomic profiling test in rare cancers before and after the National Health Insurance coverage in Japan.Org: National Cancer Center Hospital East, Kashiwa, Japan, National Cancer Center Research Institute,
Abstract
Multicenter pharmacokinetic study of pembrolizumab for non-small cell lung cancer in adults aged older than 75 years.Org: Kansai Medical University Hospital, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, National Cancer Center Hospital East, Kashiwa, Japan, Kitasato Daigaku Igakubu, Sagamihara-Shi Minami-Ku, Japan,